Crispr Therapeutics AG (CRSP) — Technical state
As of 2026-10-14 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
Trades -8.7% vs the 50-day and -5.5% vs the 200-day average, 33.1% below the 52-week high and +13.8% off the 52-week low; a golden cross printed 16 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day-8.1%
- vs 50-day-8.7%
- vs 200-day-5.5%
- 52-week band33.1% off the high · +13.8% off the low
- Streak1 consecutive up session
- CrossoverGolden cross 16 sessions ago
- 50-day crossprice crossed down through the 50-day 6 sessions ago
- Stochastic%K 11.1 · %D 16.3 · bear cross
Continue: the CRSP chart & overview · the signal board
FAQ · from the current data · as of 2026-10-14
Quick answers
What is the current Closelooknet signal on CRSP?
Mixed moving-average stack — Trades -8.7% vs the 50-day and -5.5% vs the 200-day average, 33.1% below the 52-week high and +13.8% off the 52-week low; a golden cross printed 16 sessions ago. Computed from daily closes. As of 2026-10-14; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is CRSP above its 50-day and 200-day moving averages?
As of 2026-10-14, Crispr Therapeutics AG trades -8.7% below its 50-day and -5.5% below its 200-day average, with the 20-day -8.1% away.
How far is CRSP from its 52-week high?
33.1% below the 52-week high and 13.8% above the 52-week low, as of 2026-10-14.
Mentioned on Closelooknet
Where CRSP appears in the diary — 2 pieces, newest first. Every link is our own writing.
Go deeper
Long reads
- Portfolio Construction — The Barbell Architecture, Why the Middle Is Decay
Bessembinder's 2018 paper showed that, of the US common stocks in the CRSP database from 1926 to 2016, the best-performing 4% accounted for the entire net wealth ever created — the other 96% collectively matched one-month Treasury bills.
- US Equities — Don’t Buy U.S. Stocks · Closelooknet Heresy
In his 2018 paper, Do Stocks Outperform Treasury Bills? , Bessembinder studied common stocks in the CRSP database going back to 1926.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- UCB.BR UCB SAindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- RPRX Royalty Pharma Plcindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- RVMD Revolution Medicines Incindustry
- BION.SW BB Biotech AGindustry
- ROIV Roivant Sciences Ltdindustry